Clinical Trial Update: A Clinical Study of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating trazodone hydrochloride prolonged-release tablets for depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Trazodone hydrochloride prolonged-release tablets (trazodone hydrochloride)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Depression | Phase 2, Phase 3 | Status: COMPLETED